Paul Wachter, Director at Avalanche Biotechnologies, Inc. ([AAVL]), sold 1,192 shares at $39.88 ($46K) on 2015-06-08, disclosed to the SEC on 2015-06-10.
Scheduled sale ($46k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.96 | 541 | $21K | 44.6% |
| 2 | $38.96 | 475 | $19K | 40.2% |
| 3 | $39.88 | 176 | $7K | 15.2% |
| Total | $38.64 avg | 1,192 | $46K | 100% |
| Filing → |
| [AAVL] | SELL | 2015-06-02 | $43K | — | Filing → |
| [AAVL] | SELL | 2015-05-27 | $44K | — | Filing → |
| [AAVL] | SELL | 2015-05-19 | $42K | — | Filing → |